Merkzettel Warenkorb
  • Produktbild: Adjuvant Therapy of Breast Cancer V
  • Produktbild: Adjuvant Therapy of Breast Cancer V
Band 140

Adjuvant Therapy of Breast Cancer V

Aus der Reihe Recent Results in Cancer Research

97,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.12.2011

Herausgeber

Hans-Jörg Senn + weitere

Verlag

Springer Berlin

Seitenzahl

342

Maße (L/B/H)

23,5/15,5/2 cm

Gewicht

546 g

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-3-642-79280-9

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.12.2011

Herausgeber

Verlag

Springer Berlin

Seitenzahl

342

Maße (L/B/H)

23,5/15,5/2 cm

Gewicht

546 g

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-3-642-79280-9

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Adjuvant Therapy of Breast Cancer V
  • Produktbild: Adjuvant Therapy of Breast Cancer V
  • The Control of Breast Cancer: A Look into the Future.- I. Epidemiology and Genetics of Breast Cancer.- Familial Breast Cancer.- The Food-Derived Heterocyclic Amines and Breast Cancer: A 1995 Perspective.- Menstrual Cycle Timing of Breast Cancer Resection.- Summary.- II. Biology of Breast Cancer.- Peptide Growth Factors and Breast Cancer Treatment: Recent Translational Research.- Single-Chain Fusion Toxins for the Treatment of Breast Cancer: Antitumor Activity of BR96 sFv-PE40 and Heregulin-PE40.- Tamoxifen and Endometrial Cancer: From Experiment to Patient.- Summary.- III. Prognosis of Response and Tumor Markers.- Review of Known Prognostic Variables.- Prognostic Variables and Future Predictors of Behaviour and Response.- Serum (Circulating) Tumor Markers for Breast Cancer.- Summary.- IV. Screening for Breast Cancer and Treatment of Early Lesions (Ductal Carcinoma In Situ).- A Critical Review of Screening for Breast Cancer.- Ductal Carcinoma In Situ.- Intraductal Breast Carcinoma: Experiences from The Breast Center in Van Nuys, California.- Summary.- V. Surgery for Breast Cancer: Special Issues.- Surgical Treatment of Breast Cancer Relapse.- Primary and Secondary Breast Reconstruction with Special Emphasis on the Use of Prostheses.- The Primary Use of Chemotherapy for Operable Breast Cancer: Does Systemic Therapy Make Surgery Superfluous?.- Summary.- VI. Adjuvant Systemic Therapy.- The Role of Anthracyclines in Adjuvant Chemotherapy of Breast Cancer: A Critical Appraisal.- Adjuvant Systemic Therapy: The Issues of Timing and Sequence.- Current and Future Roles of Adjuvant Endocrine Therapy in the Management of Early Carcinoma of the Breast.- Future Developments in Adjuvant Systemic Therapy for High-Risk Breast Cancer.- Summary.- VII. Radiation Therapy as Part of Primary Treatment.- Radiation Therapy in the Primary Management of Early-Stage Breast Cancer.- Quality Assurance in Early Breast Cancer Treatment: Clinical Aspects of Postoperative, External, Whole Breast Irradiation.- How To Predict the Risk of Local Relapse in the Preserved Breast.- Summary.- VIII. Women’s Health Perception and Breast Cancer: Issues of Fertility, Hormone Substitution, and Cancer Prevention.- Reproductive Potential After Adjuvant Chemotherapy for Breast Cancer.- Sex Hormones and Breast Cancer: The Issue of Hormone Replacement.- The Women’s Health Initiative: Will It Resolve the Issues?.- The Women’s Health Initiative: The Road to Scientific Clarity?.- Design and Current Status of the NSABP Breast Cancer Prevention Trial.- Summary.- IX. International Consensus Conference on Primary Treatment of Breast Cancer.- Summary.